首页> 外文期刊>Acta Radiologica >Coronary artery abnormalities in Kawasaki disease: comparison between CT and MR coronary angiography.
【24h】

Coronary artery abnormalities in Kawasaki disease: comparison between CT and MR coronary angiography.

机译:川崎病的冠状动脉异常:CT和MR冠状动脉造影的比较。

获取原文
获取原文并翻译 | 示例
       

摘要

Although CT coronary angiography (CTCA) and MR coronary angiography (MRCA) are increasingly used in patients with Kawasaki disease, comparison of coronary artery assessibility and diagnostic performance between the two imaging modalities has been rarely performed.To investigate which imaging modality, CTCA or MRCA, is better for evaluating coronary artery abnormalities in patients with Kawasaki disease.Between 2003 and 2011, 56 patients (38 boys/men; age range, 1-24 years) with Kawasaki disease underwent CTCA or MRCA (group A). Of these, 17 underwent both CTCA and MRCA (group B). Visibility of 11 coronary arterial segments in each patient was graded on a four-point scale. Coronary artery aneurysm, stenosis, and occlusion were evaluated by CTCA and MRCA, based on a reference standard obtained from cardiac catheterization, echocardiography, follow-up CTCA and MRCA, and clinical history. Coronary artery assessibility and diagnostic performance were compared between CTCA and MRCA.In per-segment analysis, more segments were assessable on CTCA than on MRCA in both groups. In per-patient analysis of group B, no significant difference in the assessibility was found between CTCA (95.0%, 128.3/135 segments) and MRCA (92.4%, 124.8/135 segments) (P > 0.05). Sensitivity, specificity, positive predictive value, negative predictive value, and accuracy of CTCA vs. MRCA were 93.1% vs. 77.9% (P < 0.001), 99.2% vs. 99.7% (P = 0.65), 96.8% vs. 98.7% (P = 0.65), 98.2% vs. 94.1% (P < 0.001), and 98.0% vs. 94.9% (P = 0.008), respectively, in group A, and 91.8% vs. 70.4% (P < 0.001), 99.5% vs. 99.5% (P = 1.000), 98.5% vs. 98.0% (P = 1.000), 97.2% vs. 91.1% (P = 0.006), and 97.6% vs. 92.3% (P = 0.004), respectively, in group B.Although CTCA and MRCA show comparable assessibility in per-patient analysis, CTCA shows higher diagnostic performance than MRCA for evaluating coronary artery abnormalities in patients with Kawasaki disease.
机译:尽管川崎病患者越来越多地使用CT冠状动脉造影(CTCA)和MR冠状动脉造影(MRCA),但很少比较两种成像方式之间的冠状动脉可评估性和诊断性能。可以更好地评估川崎病患者的冠状动脉异常.2003年至2011年之间,对56例川崎病患者(38名男孩/男性;年龄范围1-24岁)进行了CTCA或MRCA(A组)。其中,17例同时接受了CTCA和MRCA(B组)。每位患者的11个冠状动脉节段的可见性以四点量表进行分级。根据从心脏导管插入术,超声心动图检查,CTCA和MRCA的随访以及临床病史获得的参考标准,通过CTCA和MRCA对冠状动脉瘤,狭窄和闭塞进行评估。在CTCA和MRCA之间比较了冠状动脉的可评估性和诊断性能。在每段分析中,两组中CTCA上可评估的节段多于MRCA。在B组的每位患者分析中,CTCA(95.0%,128.3 / 135段)和MRCA(92.4%,124.8 / 135段)之间的可评估性没有显着差异(P> 0.05)。 CTCA与MRCA的敏感性,特异性,阳性预测值,阴性预测值和准确性分别为93.1%和77.9%(P <0.001),99.2%和99.7%(P = 0.65),96.8%和98.7% A组分别为(P = 0.65),98.2%和94.1%(P <0.001),98.0%和94.9%(P = 0.008),91.8%和70.4%(P <0.001),分别为99.5%与99.5%(P = 1.000),98.5%与98.0%(P = 1.000),97.2%与91.1%(P = 0.006)和97.6%与92.3%(P = 0.004) B组。尽管CTCA和MRCA在每位患者的分析中具有可比的评估能力,但CTCA在评估川崎病患者冠状动脉异常方面的诊断性能高于MRCA。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号